mdjbrown & alleyesonme...it has to be close to a year now reFDA CBD Drug Master File approval. That is what brought forth the FDA onsite visit in Barrie, indicating a direction to commercialize. That CBD does not require DEA rescheduling. There could be an opportunity for an earnings surprise from Q4, 2023. A lot of people forgot about that DMF.
ps: put the idiots on ignore like I did...board is so much cleaner and they don't contribute anything to begin with except their motivated garbage.